Lifetech Scientific Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
1,254
- Stock Symbol
-
01302
- Investments
-
7
- Share Price
-
$0.20
- (As of Friday Closing)
Lifetech Scientific General Information
Description
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
Contact Information
Website
www.lifetechmed.comCorporate Office
- 14th Floor, Xianjian Technology Building, Number 22, Keji South 12th Road
- High-tech Industrial Park, Nanshan District
- Shenzhen, Guangdong 518063
- China
Corporate Office
- 14th Floor, Xianjian Technology Building, Number 22, Keji South 12th Road
- High-tech Industrial Park, Nanshan District
- Shenzhen, Guangdong 518063
- China
Lifetech Scientific Stock Performance
As of 13-Nov-2026, Lifetech Scientific’s stock price is $0.20. Its current market cap is $867M with 4.4B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.20 | $0.19 | $0.16 - $0.30 | $867M | 4.4B | 23.4M |
Lifetech Scientific Financials Summary
As of 30-Jun-2026, Lifetech Scientific has a trailing 12-month revenue of $185M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 607,220 | 681,943 | 653,575 | 1,260,338 |
| Revenue | 184,913 | 190,477 | 181,689 | 179,109 |
| EBITDA | 24,731 | 34,352 | 35,847 | 31,826 |
| Net Income | 8,347 | 20,556 | 30,993 | 37,208 |
| Total Assets | 699,023 | 716,399 | 671,275 | 662,523 |
| Total Debt | 2,075 | 1,149 | 682 | 1,311 |
Lifetech Scientific Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lifetech Scientific Patents
Lifetech Scientific Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026189496-A1 | Stent graft, stent system, and method for manufacturing stent system | Pending | 14-Mar-2025 | ||
| WO-2026144561-A1 | Covered stent and stent system | Pending | 31-Dec-2024 | ||
| WO-2026144562-A1 | Covered stent and stent system | Pending | 31-Dec-2024 | ||
| WO-2026145169-A1 | Lumen stent and delivery system | Pending | 31-Dec-2024 | ||
| WO-2026144490-A1 | Occlusion device | Pending | 31-Dec-2024 |
Lifetech Scientific Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lifetech Scientific Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lifetech Scientific Investments (7)
Lifetech Scientific’s most recent deal was a Early Stage VC with Jianhu Medical for . The deal was made on 25-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jianhu Medical | 25-Jul-2025 | Early Stage VC | Diagnostic Equipment | ||
| Jenscare Biotechnology | 10-Oct-2022 | IPO | Therapeutic Devices | ||
| Yuanxin Technology (Shenzhen) | 16-Sep-2019 | Joint Venture | Medical Supplies | ||
| Shenzhen Yunma Biotechnology | 04-Jun-2019 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| China Joint Venture (Ally Bridge Group / LifeTech Scientific Corporation / Quantum Surgical) | 03-Apr-2019 | Joint Venture | Surgical Devices |
Lifetech Scientific ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.71 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Lifetech Scientific Exits (2)
Lifetech Scientific’s most recent exit was on 21-May-2018 from GRAIL. The exit was categorized as with 12 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| GRAIL | 21-May-2018 | Completed |
|
||
| Broncus Medical | 06-Jun-2012 | Later Stage VC | Completed |
|
Lifetech Scientific FAQs
-
When was Lifetech Scientific founded?
Lifetech Scientific was founded in 1999.
-
Where is Lifetech Scientific headquartered?
Lifetech Scientific is headquartered in Shenzhen, China.
-
What is the size of Lifetech Scientific?
Lifetech Scientific has 1,254 total employees.
-
What industry is Lifetech Scientific in?
Lifetech Scientific’s primary industry is Therapeutic Devices.
-
Is Lifetech Scientific a private or public company?
Lifetech Scientific is a Public company.
-
What is Lifetech Scientific’s stock symbol?
The ticker symbol for Lifetech Scientific is 01302.
-
What is the current stock price of Lifetech Scientific?
As of 13-Nov-2026 the stock price of Lifetech Scientific is $0.20.
-
What is the current market cap of Lifetech Scientific?
The current market capitalization of Lifetech Scientific is $867M.
-
What is Lifetech Scientific’s current revenue?
The trailing twelve month revenue for Lifetech Scientific is $185M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
